Skip to content

IMMUNE PHARMACEUTICALS INC: filings

Every IMMUNE PHARMACEUTICALS INC annual and quarterly report in the SEC record with the published financial measures it tagged, 30 filings, each linked to its SEC index.

Filing record ends 2018-11-14

The latest filing in this captured record is a 10-Q filed 2018-11-14. No later filing is in the SEC companyfacts record captured on 2026-09-22. IMMUNE PHARMACEUTICALS INC may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2018-11-14fiscal Q3 201834900001144204-18-059964
10-Q2018-08-14fiscal Q2 201834880001144204-18-044761
10-Q2018-05-15fiscal Q1 201835690001144204-18-028353
10-K2018-04-02fiscal FY 201740810001144204-18-018699
10-Q2017-11-14fiscal Q3 201736910001144204-17-059124
10-Q2017-08-21fiscal Q2 201734870001144204-17-044443
10-Q2017-06-14fiscal Q1 201731620001144204-17-032518
10-K2017-05-17fiscal FY 201638740001144204-17-028202
10-Q2016-11-18fiscal Q3 201631790001144204-16-135385
10-Q2016-08-15fiscal Q2 201631790001144204-16-119591
10-Q2016-05-16fiscal Q1 201632630001144204-16-102729
10-K2016-03-30fiscal FY 201537740001144204-16-091621
10-Q2015-11-16fiscal Q3 201533870001144204-15-066187
10-Q2015-08-14fiscal Q2 201531810001144204-15-049974
10-Q2015-05-15fiscal Q1 201530590001144204-15-031739
10-K2015-04-15fiscal FY 201436710001144204-15-023077
10-Q2014-11-17fiscal Q3 201436980001144204-14-069277
10-Q2014-08-14fiscal Q2 201434950001144204-14-049508
10-Q2014-05-20fiscal Q1 201431750001437749-14-009586
10-K2014-04-09fiscal FY 201333880001437749-14-006363
10-Q2013-11-19fiscal Q3 2013371310001437749-13-015039
10-Q2013-08-02fiscal Q2 201334910001437749-13-009785
10-Q2013-05-20fiscal Q1 201331610001104659-13-043226
10-K2013-03-05fiscal FY 201234680001104659-13-017543
10-Q2012-11-14fiscal Q3 201234860001104659-12-077883
10-Q2012-08-10fiscal Q2 201236930001104659-12-056872
10-Q2012-05-10fiscal Q1 201229590001104659-12-035761
10-K2012-03-30fiscal FY 201128750001104659-12-022842
10-Q2011-11-10fiscal Q3 201128740001104659-11-062950
10-Q2011-08-15fiscal Q2 201129710000950123-11-077568

Inspect the source

Entity
IMMUNE PHARMACEUTICALS INC / CIK 0001208261
Captured
SEC response SHA-256
a0d08e3288bd42a00d53c5f3f65d03f35e9fc6d8d75cee3382bd431d3e982a23

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001208261.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))